Successful myeloablative unrelated bone marrow transplantation for relapsed intravascular large B cell lymphoma after autologous peripheral blood stem cell transplantation
Authors:
- 22 October 2020
- journal article
- letter
- Published by Springer Nature in Annals of Hematology
- Vol. 100 (12) , 3067-3069
Abstract
No abstract availableThis publication has 8 references indexed in Scilit:
- Rituximab, cyclophosphamide, doxorubicin, vincristine, and prednisolone combined with high-dose methotrexate plus intrathecal chemotherapy for newly diagnosed intravascular large B-cell lymphoma (PRIMEUR-IVL): a multicentre, single-arm, phase 2 trialThe Lancet Oncology, 2020
- Outcome of patients receiving consolidative autologous peripheral blood stem cell transplantation in the frontline treatment of intravascular large B-cell lymphoma: Adult Lymphoma Working Group of the Japan Society for Hematopoietic Cell TransplantationBone Marrow Transplantation, 2019
- Intravascular large B-cell lymphoma: a chameleon with multiple faces and many masksBlood, 2018
- Chimeric Antigen Receptor T Cells in Refractory B-Cell LymphomasNew England Journal of Medicine, 2017
- Outcomes of diffuse large B-cell lymphoma patients relapsing after autologous stem cell transplantation: an analysis of patients included in the CORAL studyBone Marrow Transplantation, 2016
- Allogeneic transplantation provides durable remission in a subset of DLBCL patients relapsing after autologous transplantationBritish Journal of Haematology, 2016
- Central nervous system involvement in intravascular large B‐cell lymphoma: A retrospective analysis of 109 patientsCancer Science, 2010
- Reduced-intensity unrelated cord blood transplantation for patients with advanced malignant lymphomaTransplantation and Cellular Therapy, 2005